Sarah Tasian

53PUBLICATIONS
389CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Haematological tumoursAdolescent healthInformation extraction and fusionInfant and child health
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (53)

|Sep 21, 2026
Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immunotherapy for the treatment of acute leukemia, version 2.0.

|Sep 02, 2026
Multimodal analysis of CD38 in T-cell Acute Lymphoblastic Leukemia Identifies Combinatorial Therapeutic Strategies.

|Jul 24, 2026
AAML1831: A Phase III Trial Comparing Standard Induction Therapy With CPX-351 in De Novo Pediatric AML: A Report From the Children's Oncology Group.

|May 08, 2026
Gilteritinib and chemotherapy in children with relapsed/refractory FLT3-ITD AML: results from the phase 1/2 SKIPPER trial.

|Apr 17, 2026
The Common Fund Data Ecosystem (CFDE).

|Mar 23, 2026
From the bench of molecular understanding to the bedside of optimal therapy for BCR::ABL1 and ABL-class acute lymphoblastic leukemia in children and adolescents.

Sarah K Tasian, Judith M Boer, Monique L den Boer

Pageof 9

Frequent Collaborators

5 joint publications

Mignon L Loh

4 joint publications

Katharina E Hayer

4 joint publications

Richard Aplenc

4 joint publications

Lisa Eidenschink Brodersen